feed,title,long_url,short_url
Benzinga,"The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs",https://benzinga.com/general/biotech/21/07/22245120/the-daily-biotech-pulse-erytech-jumps-on-fast-track-designation-glaxosmithkline-fda-nod-alnylams-,https://j.mp/2TOC3lm
Benzinga,GlaxoSmithKline's Scores FDA Approval For First IL-5 Inhibitor In Nasal Polyps,https://benzinga.com/general/biotech/21/07/22245039/glaxosmithklines-scores-fda-approval-for-first-il-5-inhibitor-in-nasal-polyps,https://j.mp/378DTAn
